We are live on ! Find out more
CPHI icon

China Pharma Holdings
CPHI

10 hedge funds and large institutions have $262K invested in China Pharma Holdings in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

43% more funds holding

Funds holding: 7 → 10 (+3)

0% less ownership

Funds ownership: 0% → 0% (-0%)

38% less capital invested

Capital invested by funds: $424K → $262K (-$162K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 4

Holders
10
Holders Change
+3
Holders Change %
+42.86%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
–
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$10K
2
TSS
Two Sigma Securities
New York
+$5.64K
3
UBS Group
UBS Group
Switzerland
+$3.97K
4
JPLA
Joseph P. Lucia & Associates
New York
+$3.76K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$44K
2
VF
Virtu Financial
New York
-$35.3K
3
HF
HRT Financial
New York
-$19.2K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$11K
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$1.46K

CPHI Hedge Fund Activity: Q1 2022 in Review

10 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q1 2022, worth a combined $262K — down 38% from $424K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new CPHI positions and 1 closed out — a net gain of 3 holders — while 0 added to existing stakes and 4 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $10K. The largest seller was Renaissance Technologies, cutting an estimated $44K.

  • 10 institutional investors held China Pharma Holdings (CPHI) as of Q1 2022, up from 7 in Q4 2021.
  • Funds reported $262K of China Pharma Holdings stock for Q1 2022, down 38% quarter-over-quarter.
  • 4 funds opened new China Pharma Holdings positions in Q1 2022 and 1 closed out, a net change of +3 holders.
  • The largest China Pharma Holdings buyer in Q1 2022 was Millennium Management, an estimated $10K added.
  • The largest China Pharma Holdings seller in Q1 2022 was Renaissance Technologies, an estimated $44K sold.

Based on aggregated 13F filings for Q1 2022.